Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Discovery Grants Program - Individual

University of Saskatchewan

$29,170.00

The role of dicer and argonaute in HCV replication

FY 2008-09

Summary
Our research focuses on how Hepatitis C virus replicates in human cells. Because viruses are obligate intracellular parasites they must avoid cellular defense mechanisms and take over basic cellular operations in order to grow. Thus studying how viruses replicate often reveals novel cellular processes. We are interested in how the replication of HCV is influenced by host cell RNA interference (RNAi) activity. Andrew Fire and Craig Mello first discovered RNAi in 1998 and were recently awarded a Nobel Prize for their work. In plants, RNAi is an important antiviral defense mechanism in which single stranded viral genomic RNA is targeted for destruction by the presence of double stranded viral RNA intermediates. In mammalian cells RNAi works quite differently. Naturally occurring short double stranded RNAs, called microRNA activate similar machinery, but instead of targeting viral RNA for destruction they inhibit messenger RNA from being used for protein synthesis. We are interested in the influence of RNA interference activity on the human virus Hepatitis C. We disabled RNAi activity in cells and were surprised to find that virus replication decreased. This suggested that instead of limiting virus replication as it does in plants, RNAi activity appears to benefit the replication of HCV. Subsequent evidence suggests that this RNAi activity may be novel since it does not resemble other RNAi functions. Our research program is designed to further our knowledge of this undefined cellular regulation mechanism and determine how HCV, a model virus of the Flaviviridae family of single stranded viruses uses this system for its own benefit. In particular we will study the biochemical interactions between HCV and RNAi related proteins, and to find genetic links between HCV and RNA interference activity. These studies will further our knowledge of cell regulation and virus replication and may reveal links between virus replication and pathogenesis.
Program
Discovery Grants Program - Individual
Location
Saskatchewan, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
342475-2007
Name nom
Wilson, Joyce
Department département
Microbiology and Immunology
Organization id
16
Institution établissement
University of Saskatchewan
Province en
Saskatchewan
Province fr
Saskatchewan
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2008
Competition year année de concours
2007
Award amount
29170
Program id
RGPIN
Program nane en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
33
Committee name en
Molec. & Develop. Genetics
Committee name fr
Gén. moléculaire et dévelop.
Area of application code
1201
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Life sciences (including biotechnology)
Area of application fr
Sciences de la vie (y compris biotechnologie)
Research subject code
5202
Research subject group en
Microbiology
Research subject group fr
Microbiologie
Research subject en
Virology
Research subject fr
Virologie
Partie
2
Nb partie
5
Application title
The role of dicer and argonaute in HCV replication
Keyword
NA
Application summary
Our research focuses on how Hepatitis C virus replicates in human cells. Because viruses are obligate intracellular parasites they must avoid cellular defense mechanisms and take over basic cellular operations in order to grow. Thus studying how viruses replicate often reveals novel cellular processes. We are interested in how the replication of HCV is influenced by host cell RNA interference (RNAi) activity. Andrew Fire and Craig Mello first discovered RNAi in 1998 and were recently awarded a Nobel Prize for their work. In plants, RNAi is an important antiviral defense mechanism in which single stranded viral genomic RNA is targeted for destruction by the presence of double stranded viral RNA intermediates. In mammalian cells RNAi works quite differently. Naturally occurring short double stranded RNAs, called microRNA activate similar machinery, but instead of targeting viral RNA for destruction they inhibit messenger RNA from being used for protein synthesis. We are interested in the influence of RNA interference activity on the human virus Hepatitis C. We disabled RNAi activity in cells and were surprised to find that virus replication decreased. This suggested that instead of limiting virus replication as it does in plants, RNAi activity appears to benefit the replication of HCV. Subsequent evidence suggests that this RNAi activity may be novel since it does not resemble other RNAi functions. Our research program is designed to further our knowledge of this undefined cellular regulation mechanism and determine how HCV, a model virus of the Flaviviridae family of single stranded viruses uses this system for its own benefit. In particular we will study the biochemical interactions between HCV and RNAi related proteins, and to find genetic links between HCV and RNA interference activity. These studies will further our knowledge of cell regulation and virus replication and may reveal links between virus replication and pathogenesis.